Shuanshuan Xie Selected Research

CAP1-6D

1/2022	Phosphorylation of CAP1 regulates lung cancer proliferation, migration, and invasion.
8/2019	Adenylyl cyclase‑associated protein 1‑targeted nanoparticles as a novel strategy for the treatment of metastatic non‑small cell lung cancer.
1/2018	Phosphorylation of the Cytoskeletal Protein CAP1 Regulates Non-Small Cell Lung Cancer Survival and Proliferation by GSK3β.
4/2017	Systematic analysis of gene expression alterations and clinical outcomes of adenylate cyclase-associated protein in cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Shuanshuan Xie Research Topics

Disease

7	Lung Neoplasms (Lung Cancer) 01/2022 - 01/2018
5	Neoplasms (Cancer) 01/2022 - 04/2017
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 01/2018
2	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2022 - 01/2019
2	Neoplasm Metastasis (Metastasis) 01/2022 - 08/2019
2	Inflammation (Inflammations) 01/2021 - 03/2019
2	Chronic Obstructive Pulmonary Disease (COPD) 01/2021 - 05/2016
2	Fever (Fevers) 05/2016 - 01/2014
2	Pneumonia (Pneumonitis) 05/2016 - 01/2014
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2021
1	Adenocarcinoma 01/2021
1	Adenocarcinoma of Lung 01/2021
1	Emphysema 01/2021
1	Pleural Tuberculosis 10/2017
1	Hemoptysis 05/2016
1	Dyspnea (Shortness of Breath) 05/2016
1	Coronary Disease (Coronary Heart Disease) 05/2016
1	Chest Pain (Chest Pains) 05/2016
1	Pulmonary Embolism 05/2016
1	Asthma (Bronchial Asthma) 04/2015
1	Hypertension (High Blood Pressure) 01/2015
1	Body Weight (Weight, Body) 03/2014
1	Obesity 03/2014
1	Cough 01/2014
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2014
1	Respiratory Insufficiency (Respiratory Failure) 01/2014

Drug/Important Bio-Agent (IBA)

4	CAP1-6DIBA 01/2022 - 04/2017
4	Proteins (Proteins, Gene)FDA Link 01/2022 - 04/2017
3	Messenger RNA (mRNA)IBA 01/2022 - 03/2014
2	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2021 - 10/2017
1	C-Reactive ProteinIBA 01/2021
1	Vancomycin FDA LinkGeneric 03/2019
1	Phosphotransferases (Kinase)IBA 01/2018
1	CarcinogensIBA 01/2018
1	Adenylyl Cyclases (Adenylyl Cyclase)IBA 04/2017
1	fibrin fragment D (D-dimer)IBA 05/2016
1	Troponin IIBA 05/2016
1	Transforming Growth Factor beta (TGF-beta)IBA 04/2015
1	SugarsIBA 01/2015
1	SaltsIBA 01/2015
1	Streptozocin (Streptozotocin)FDA Link 01/2015
1	HDL CholesterolIBA 03/2014
1	Emodin (Archin)IBA 03/2014
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2014
1	omega-Chloroacetophenone (Mace)IBA 01/2014
1	Hormones (Hormone)IBA 01/2014

Therapy/Procedure

3	Drug Therapy (Chemotherapy) 01/2022 - 01/2019
2	Therapeutics 01/2021 - 01/2014
2	Radiotherapy 08/2020 - 01/2019
1	Segmental Mastectomy (Lumpectomy) 01/2021
1	Length of Stay 01/2021
1	Adjuvant Chemotherapy 01/2019
1	Intraperitoneal Injections 01/2015